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Past exposure to sun, skin phenotype, and risk of
multiple sclerosis: case-control study
I A F van der Mei, A-L Ponsonby, T Dwyer, L Blizzard, R Simmons, B V Taylor, H Butzkueven,
T Kilpatrick
Abstract
Objective To examine whether past high sun
exposure is associated with a reduced risk of multiple
sclerosis.
Design Population based case-control study.
Setting Tasmania, latitudes 41-3°S.
Participants 136 cases with multiple sclerosis and 272
controls randomly drawn from the community and
matched on sex and year of birth.
Main outcome measure Multiple sclerosis defined by
both clinical and magnetic resonance imaging criteria.
Results Higher sun exposure when aged 6-15 years
(average 2-3 hours or more a day in summer during
weekends and holidays) was associated with a
decreased risk of multiple sclerosis (adjusted odds
ratio 0.31, 95% confidence interval 0.16 to 0.59).
Higher exposure in winter seemed more important
than higher exposure in summer. Greater actinic
damage was also independently associated with a
decreased risk of multiple sclerosis (0.32, 0.11 to 0.88
for grades 4-6 disease). A dose-response relation was
observed between multiple sclerosis and decreasing
sun exposure when aged 6-15 years and with actinic
damage.
Conclusion Higher sun exposure during childhood
and early adolescence is associated with a reduced risk
of multiple sclerosis. Insufficient ultraviolet radiation
may therefore influence the development of multiple
sclerosis.
Introduction
Multiple sclerosis is a chronic demyelinating disease of
the central nervous system. Contributing factors
include a defect in immunological self tolerance result-
ing in a T helper cell type 1 mediated attack on myelin
proteins.1 One of the most striking epidemiological
features of multiple sclerosis is a gradient of increasing
prevalence with latitude.2 An inverse association
between solar radiation and prevalence of multiple
sclerosis was first observed in 1960.3 Recent photo-
immunological work has rekindled interest in this
observation because ultraviolet radiation can attenuate
T helper cell type 1 mediated immune responses
through several mechanisms.4 Also, administration of
ultraviolet radiation or 1,25-dihydroxycholecalciferol,
the active form of vitamin D3, which is produced under
the influence of ultraviolet radiation,5 has shown
protective effects against the induction or progression
of experimental allergic encephalomyelitis.6 7
In humans, ultraviolet radiation or vitamin D may
also protect against multiple sclerosis. A strong
ecological association between regional levels of ultra-
violet radiation and prevalence of multiple sclerosis is
evident in Australia (r = − 0.91).8 In a death certificate
based case-control study, high residential or occupa-
tional exposure to sunlight was negatively associated
with mortality from multiple sclerosis.9 Exposure to
ultraviolet radiation early in life may alter immunologi-
cal development during a critical developmental
phase. However, the finding of a strong latitudinal
gradient of prevalence of multiple sclerosis in Australia
even among immigrants from the United Kingdom
and Ireland (70% who migrated after age 15) suggests
that cumulative exposure to ultraviolet radiation or
exposure later in life might also be important.10
Tasmania, the island state of Australia, is located at
latitudes 41-3°S and has a high prevalence of multiple
sclerosis at 75.6 per 100 000 population.11 We
conducted a case-control study in Tasmania to
examine whether high past sun exposure was
associated with a reduced risk of multiple sclerosis.
Participants and methods
Our source population consisted of people aged under
60 years who were residents of Tasmania and who had
at least one grandparent who was born in Tasmania.
Written consent was obtained from all participants.
Cases
Cases were members of the source population who
had a diagnosis of multiple sclerosis. To recruit partici-
pants, information evenings were held for members of
the local multiple sclerosis societies, and information
packs were sent out to neurologists, general physicians,
general practitioners, and pharmacists, who were
encouraged to publicise the posters and to inform
people with multiple sclerosis about the programme.
Neurologists in the south of the state sent letters to eli-
gible patients inviting them to participate and verbally
encouraged newly diagnosed patients to participate. In
total, 169 people responded. We included 136 cases in
the final sample: 30 people (18%) did not meet the
study criteria for diagnosis of multiple sclerosis, one
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person refused a neurological assessment, one person
died before interview, and one person deteriorated and
was unable to take part. Respondents were interviewed
and examined by one of the participating neurologists.
Magnetic resonance images subsequently confirmed
the diagnosis for 134 cases (99%), and for the other two
cases we obtained the reports of previous scans.
Eligible cases had cerebral abnormalities on magnetic
resonance imaging consistent with multiple sclerosis,
as defined by Paty et al, and definite multiple sclerosis
using the criteria of Poser et al.12 13 Cases with a classifi-
cation of primary progressive multiple sclerosis had to
exhibit progressive neurological disability for at least
one year, had to have no other better explanation for
the clinical features, and had to have relevant spinal
cord abnormalities and changes on cerebral magnetic
resonance imaging consistent with demyelination. The
cases were also included in a genetic study, for which a
haplotype analysis was conducted on the human
leucocyte antigen region.14
Controls
Controls were selected from the source population
using the roll of registered electors, a comprehensive
listing of the population maintained by the state
electoral office of Tasmania. We randomly selected two
controls for each case and matched them to the index
case on sex and year of birth. Overall, 272 of 359 eligi-
ble controls participated (response rate 76%). In an
unmatched design, we required at least 100 cases and
200 controls to detect an odds ratio of 2.0 or 0.5 for the
effect of a dichotomous exposure where 40% of the
controls were exposed.
Measurements
Time in sun
Two research assistants conducted all interviews and
measurements between March 1999 and June 2001.
Participants were asked about the amount of time they
would normally have spent in the sun during weekends
and holidays in winter and summer (“time in the sun”
question), using questions validated for teenagers in this
climate.15 Answers to the time in the sun question for
winter predict levels of serum 25-hydroxycholecalciferol
in 8 year old Tasmanian children.16 The standardised
questionnaire included questions on measures to
protect against the sun, use of vitamin D supplements at
ages 10-15 years, medical history (including infections
and immunisations), and other factors suggested by past
work to be associated with multiple sclerosis. For the
timing of exposures we obtained either the exact age or
the five year age range in which the exposure occurred.17
Before interview, participants were asked to fill in a life-
time calendar for each year of their life. During the
interview, participants answered the time in the sun
question for summer only for each year of their life, and
from the information in the calendar we identified
blocks of years where time in the sun was constant or
not. The  statistic (95% confidence interval) between
the questionnaire based measure and the calendar
measure (using the mean value) for ages 6-10, 11-15,
and 16-20 years was 0.54 (0.47 to 0.61), 0.51 (0.44 to
0.58), and 0.44 (0.37 to 0.50), respectively. No difference
in agreement was found between cases and controls.
Actinic damage
Silicone casts of the skin surface of the hand, measuring
actinic damage, were used as an objective marker of
cumulative lifetime sun exposure. This measure has
been associated with living in a location with high ultra-
violet radiation, lifetime exposure to sun, outdoor occu-
pations and leisure activities, solar keratosis, and basal
and squamous cell cancer.18–21 Silicone liquid was mixed
with catalyst and applied to the dorsum of the
participant’s left hand. After seven minutes, the cast was
removed. The lines on the underside of the cast were
examined under a low power dissecting microscope and
graded by one observer from 1 (undamaged skin) to 6
(severe deterioration).22 By age 14 up to 70% of Austral-
ians show detectable skin damage caused by the sun.18 In
Nambour (latitude 27°S), Queensland, 72% of men and
47% of women had moderate to severe deterioration of
the skin by their 30s.20 Age and sex have also been shown
to be strong predictors of the amount of actinic damage,
and we controlled for these two factors through our
matched design.18 20 21
Skin phenotype
Skin phenotype was assessed with a spectropho-
tometer at the upper inner arm and buttock-body sites
usually not exposed to sunlight. Cutaneous melanin
density was estimated from the skin reflectance of light
centred at 400 nm and 420 nm.23 Skin colour at the
upper inner arm was also assessed visually by the
research assistants. The standardised questionnaire
included a question on lifetime sunburns where the
pain lasted more than two days, a measure that reflects
both skin phenotype and sun exposure behaviour. The
research assistant also recorded the number of naevi
greater than 5 mm on the left arm, hair and eye colour,
height, and weight.
Data analysis
Pearson correlations were calculated as measures of
linear association. Odds ratios and 95% confidence
intervals were estimated by conditional logistic
regression (STATA 7.0). Tests for trend of categorical
variables were undertaken by replacing the binary pre-
dictors with a single predictor, taking category rank
scores. The scaled variables for melanin and naevi were
dichotomised at previously used cut-off points.24
Analysis of actinic damage was restricted to 323 high
quality casts. The recording of year by year exposure by
the lifetime calendar allowed an estimation of average
exposure at any age. We did this for ages 6-10, 11-15,
and 16-20 and for ages 6-10, 6-15, 6-20, and so on. To
aggregate and then average annual exposure, the
categories were assigned rank scores. For each age
span in the figure the average sun exposure was
dichotomised at 2-3 hours a day. For table 4 and the
figure, the sample was limited to cases and their
matched controls who had not experienced any symp-
toms of multiple sclerosis before or during the age
span. To take account of duration of disease, we strati-
fied by time elapsed since the first symptom of multiple
sclerosis: 0-5, 6-10, 11-15, 16-20, and > 20 years. A test
of interaction was conducted using the coefficient and
standard error of a product term of exposure to sun
and duration of disease. In analysis, controls were given
the years of duration or the age at onset (age at first
symptom) of their case pair. Proportional hazard
Papers
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regression was used among cases to assess the effect of
sun exposure and skin phenotype on the age at onset
of disease.
Results
Overall, 68% (n = 92) of the cases were female, and
most of the cases and controls were born in Tasmania
and living there at age 10 (table 1). Sixty five per cent of
the cases had relapsing remitting multiple sclerosis
(table 2) Although only of borderline significance, the
odds of having light skin colour ( < 2% melanin) was
1.59 times higher for cases than for controls. Skin col-
our assessed by the research assistant showed a signifi-
cant relation with multiple sclerosis, but reported
tendency to burn or tanning ability did not (table 2).
Childhood sun exposure
People with multiple sclerosis were less likely to report
severe sunburn episodes during their lifetime, despite
their fairer skin (table 3). We observed a strong inverse
association between sun exposure in childhood and
adolescence and multiple sclerosis (table 4). For exam-
ple, cases were less likely than controls to report higher
levels ( > 1 hour a day) of exposure during winter at age
6-10 years (odds ratio 0.47, 95% confidence interval
0.26 to 0.84). This inverse association was observed for
exposure both in winter and in summer (see table 4).
Compared to bivariate analysis, including both
summer and winter questionnaire based measures for
exposure as dichotomised terms in the model left the
estimated effect of exposure in winter almost
unchanged (adjusted odds ratio 0.52, 0.28 to 0.95 at
age 6-10 years), but greatly reduced the effect of expo-
sure in summer (0.63, 0.30 to 1.35 at age 6-10 years).
This was found irrespective of the age at exposure.
We then estimated the effect of average sun
exposure at age 6-15 years on multiple sclerosis from
the year by year calendar (table 5) taking into account
other factors that related to multiple sclerosis (low
melanin density at the upper inner arm, smoking, his-
tory of glandular fever, no immunisation for rubella in
early life, high education, exposure to fibreglass and
resin before age 17, exposure to smoke fumes before
age 17, and exposure to smoke fumes between age 17
and the age of diagnosis). Intake of vitamin D
supplements at age 10-15 years was not associated with
multiple sclerosis. After controlling for smoking and
melanin density at the upper inner arm, the adjusted
odds ratio was 0.31 (0.16 to 0.59) for high sun exposure
at age 6-15 years. Additional adjustment for the other
factors made no important difference to the results
(see table 5).
Lifetime sun exposure
The figure shows the odds ratios for higher sun expo-
sure by age using the calendar data. The odds ratio
estimates of the apparent protective effect of higher
exposure were greatest for age spans before 15 (6-10
years: 0.43, 0.21 to 0.88; 6-15 years: 0.40, 0.20 to 0.80).
Inclusion of later years into the cumulative lifespan
measure diluted the effect. We repeated the analysis on
a subgroup of participants who had indicated on a
checklist before interview that they did not believe that
climatic factors such as sun exposure were an
important cause of multiple sclerosis. For this group,
the protective effect of past exposure was even stronger
than for the total group (figure).
Greater levels of actinic damage were also
associated with a reduced risk of multiple sclerosis
(grades 4-6 v grade 3: 0.32, 0.11 to 0.88) with evidence
of a dose-response relation (table 6). We adjusted for
melanin density at the upper inner arm because it was
associated with less actinic damage. Doing so increased
the magnitude of the odds ratios. We also adjusted for
total sun exposure after onset of multiple sclerosis to
remove the contribution of this factor to the observed
associations. Duration of disease was not strongly asso-
ciated with past sun exposure (for example, correlation
with exposure to age 15, r = − 0.08) or actinic damage
after adjustment for age (r = − 0.02). Moreover, the
relative risk estimates for neither exposure to age 15
nor actinic damage differed by duration of disease, and
the protective effects were also observed among cases
of recent ( ≤ 5 years) onset (adjusted odds ratio 0.58 for
2-3 hours or more of exposure a day before age 15;
0.50 for grades 4-6 actinic damage), although the esti-
mates were more imprecise. We then assessed whether
higher exposure before age 15 and greater actinic
Table 1 Personal characteristics of cases and controls
Characteristics Cases (n=136) Controls (n=272)
No (%) female 92 (68) 184 (68)
No (%) male 44 (32) 88 (32)
Female to male ratio 2.1:1 2.1:1
Mean (SD) age (years) 43.5 (9.3) 43.6 (9.2)
No (%) born in Tasmania 131 (96) 258 (95)*
No (%) living in Tasmania at age 10 131 (96) 265 (97)
Mean (SD) height (cm) 166.9 (9.0) 166.1 (8.9)
Mean (SD) weight (kg) 72.9 (14.4) 76.2 (16.1)
*Unknown for one participant.
Table 2 Disease specific characteristics of cases. Values are numbers (percentages) of
cases unless stated otherwise
Characteristics Cases (n=136)
Mean (SD) age at diagnosis 34.6 (9.1)
Mean (SD) age at first symptoms 31.0 (9.1)
Mean (SD) duration of multiple sclerosis since diagnosis (years) 9.4 (7.5)
Mean (SD) duration of multiple sclerosis since first symptoms (years) 12.1 (8.0)
Mean (SD) EDSS score 3.5 (2.2)
Frequency of DRB1*1501—DQB1*0602 haplotype 66 (54)
Type of multiple sclerosis:
Relapsing remitting 89 (65)
Secondary progressive 35 (27)
Primary progressive 10 (8)
Frequency of DRB1*1501-DQB1*0602 not available for 13 cases. Type of multiple sclerosis not available for
two cases.
Table 3 Odds ratios for multiple sclerosis and measures of skin phenotype, history of
sunburn, and skin naevi
Factor
No (%) of cases
exposed
No (%) of controls
exposed
Unadjusted odds
ratio (95% CI)
Melanin density at upper inner arm
(<2% v ≥2%)
69/127 (54) 104/236 (44) 1.59 (0.99 to 2.55)
Skin colour* (fair or medium to fair v
olive to medium or olive)
87/132 (66) 142/264 (54) 1.62 (1.05 to 2.51)
Tendency to burn (burn within 1 h v
burn after >1 h)
81/136 (60) 151/272 (56) 1.19 (0.77 to 1.83)
Ability to tan (light or no tan v dark or
medium tan)
48/136 (35) 91/272 (34) 1.11 (0.68 to 1.80)
Lifetime sunburn (any v none) 104/135 (77) 232/272 (85) 0.55 (0.32 to 0.96)
No of naevi >5 mm on left arm (≥3 v <3) 25/129 (19) 51/263 (19) 0.94 (0.54 to 1.63)
*At upper inner arm, assessed by research assistant.
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damage were each important in predicting the risk of
multiple sclerosis. Compared to bivariate analysis,
including both in the same model as linear terms left
the effect of each factor almost unchanged.
Age at onset
To assess the effect of sun exposure at a specific time
immediately before onset of disease, we created
variables of the participants’ exposure at particular
years before the onset of multiple sclerosis by using the
calendar. The odds ratios (95% confidence intervals)
for 2-3 hours or more exposure to the sun in summer
during weekends and holidays were 0.95 (0.55 to 1.64),
0.92 (0.55 to 1.54), and 1.06 (0.65 to 1.74) for 10 years,
five years, and one year before the onset of multiple
sclerosis, respectively. Thus, in contrast to the inverse
association between sun exposure in early life or
actinic damage and multiple sclerosis, there was no
evidence that exposure at these particular years in the
decade before the onset of disease was important.
Finally, we examined age at onset of multiple
sclerosis among cases. No evidence was found that
increasing exposure from age 6-15 years or lifetime
actinic damage were associated with earlier onset of
disease. However, skin phenotype did relate to age at
onset. Low melanin density at the buttock and fair skin
were associated with earlier onset of disease.
Discussion
Higher sun exposure during childhood and early ado-
lescence and greater actinic damage are associated
with a decreased risk of multiple sclerosis. Both exhib-
ited a dose-response relation with multiple sclerosis.
The inverse association between past exposure to
ultraviolet radiation and multiple sclerosis was consist-
ently found regardless of whether exposure was
measured by questionnaire, calendar, or actinic
damage. These findings are consistent with other work
Table 5 Odds ratios for multiple sclerosis and average time in sun in summer during
weekends and holidays at age 6-15 years using calendar measure
Sun exposure
No (%) of
cases
No (%) of
controls
Unadjusted odds
ratio (95% CI)
Adjusted odds ratio*
(95% CI)
Time in sun (h/day):
<1 4 (3.0) 4 (1.5)
1-2 16 (11.9) 14 (5.2) 1 1
2-3 22 (16.3) 39 (14.4) 0.51 (0.22 to 1.17) 0.42 (0.16 to 1.09)
3-4 30 (22.0) 65 (24.1) 0.40 (0.18 to 0.89) 0.32 (0.13 to 0.80)
>4 63 (46.7) 148 (54.8) 0.37 (0.18 to 0.76) 0.26 (0.11 to 0.60)
Linear trend P=0.01 P<0.01
Dichotomised (≥2-3 v ≤1-2) 0.39 (0.22 to 0.70) 0.31 (0.16 to 0.59)
*Adjusted for melanin density at upper inner arm and whether ever smoked before age of diagnosis.
Table 4 Odds ratios for multiple sclerosis and reported measures of sun exposure in childhood and adolescence
Sun exposure
Age 6-10 Age 11-15 Age 16-20
No (%) of
cases
No (%) of
controls
Unadjusted odds
ratio (95% CI)
No (%) of
cases
No (%) of
controls
Unadjusted odds
ratio (95% CI)
No (%) of
cases
No (%) of
controls
Unadjusted odds
ratio (95% CI)
In winter, by questionnaire
Time in sun (h/day):
<1 26 (19.1) 27 (10.0) 1 22 (16.3) 28 (10.3) 1 29 (21.3) 37 (13.6) 1
1-2 29 (21.3) 61 (22.7) 0.50 (0.24 to 1.00) 29 (21.5) 69 (25.4) 0.55 (0.27 to 1.10) 37 (27.2) 84 (30.9) 0.59 (0.32 to 1.07)
2-3 26 (19.1) 64 (23.8) 0.43 (0.21 to 0.87) 30 (22.2) 65 (23.9) 0.61 (0.30 to 1.22) 26 (19.1) 53 (19.5) 0.63 (0.32 to 1.24)
3-4 14 (10.3) 34 (12.6) 0.44 (0.19 to 1.01) 22 (16.3) 37 (13.6) 0.76 (0.36 to 1.61) 17 (12.5) 39 (14.3) 0.56 (0.26 to 1.22)
>4 41 (30.2) 83 (30.9) 0.50 (0.26 to 0.98) 32 (23.7) 73 (26.8) 0.57 (0.28 to 1.14) 27 (19.9) 59 (21.7) 0.60 (0.30 to 1.17)
Linear trend P=0.18 P=0.45 P=0.22
Dichotomised (≥1-2 v <1) 0.47 (0.26 to 0.84) 0.60 (0.33 to 1.09) 0.59 (0.35 to 1.01)
In summer, by questionnaire
Time in sun (h/day):
<1 6 (4.4) 8 (3.0)
1
3 (2.2) 2 (0.7)
1
11 (8.1) 13 (4.8)
1
1-2 15 (11.0) 15 (5.6) 13 (9.6) 26 (9.6) 19 (14.0) 37 (13.6)
2-3 20 (14.7) 39 (14.4) 0.59 (0.27 to 1.28) 20 (14.7) 37 (13.6) 0.94 (0.40 to 2.17) 22 (16.0) 64 (23.6) 0.55 (0.28 to 1.10)
3-4 17 (12.5) 48 (17.8) 0.39 (0.17 to 0.88) 27 (19.9) 61 (22.4) 0.77 (0.35 to 1.68) 26 (19.1) 61 (22.5) 0.71 (0.38 to 1.35)
>4 78 (57.4) 160 (59.3) 0.55 (0.30 to 1.03) 73 (53.7) 146 (53.7) 0.88 (0.44 to 1.74) 58 (42.7) 96 (35.4) 1.00 (0.57 to 1.78)
Linear trend P=0.15 P=0.72 P=0.56
Dichotomised (≥2-3 v
≤1-2) 0.50 (0.24 to 1.02) 0.86 (0.44 to 1.66) 0.79 (0.47 to 1.33)
In summer, by calendar
Time in sun (h/day):
<1 2 (1.5) 2 (0.7)
1
4 (2.9) 2 (0.7)
1
6 (4.4) 8 (2.9)
1
1-2 17 (12.5) 14 (5.2) 11 (8.1) 12 (4.4) 20 (14.7) 47 (17.3)
2-3 18 (13.2) 23 (8.5) 0.63 (0.23 to 1.73) 27 (19.9) 40 (14.7) 0.65 (0.26 to 1.61) 27 (19.9) 58 (21.3) 0.99 (0.50 to 1.95)
3-4 19 (14.0) 44 (16.3) 0.35 (0.14 to 0.88) 22 (16.2) 53 (19.5) 0.39 (0.16 to 0.95) 30 (22.1) 55 (20.2) 1.16 (0.59 to 2.26)
>4 80 (58.8) 187 (69.3) 0.34 (0.16 to 0.74) 72 (52.9) 165 (60.7) 0.40 (0.18 to 0.89) 53 (39.0) 104 (38.2) 1.09 (0.60 to 1.97)
Linear trend P<0.01 P=0.01 P=0.70
Dichotomised (≥2-3 v ≤1-2) 0.36 (0.17 to 0.76) 0.44 (0.20 to 0.94) 1.07 (0.63 to 1.85)
Table 6 Odds ratios for multiple sclerosis and levels of actinic damage on dorsum of
hand
Actinic damage
No (%) of
cases
No (%) of
controls
Unadjusted odds
ratio (95% CI)
Adjusted odds ratio*
(95% CI)
Grade 3 18 (17.1) 21 (9.6) 1 1
Grade 4 34 (32.4) 59 (27.1) 0.47 (0.19 to 1.13) 0.32 (0.10 to 0.98)
Grade 5 41 (39.0) 78 (35.8) 0.37 (0.15 to 0.90) 0.33 (0.12 to 0.96)
Grade 6 12 (11.4) 60 (27.5) 0.14 (0.05 to 0.42) 0.17 (0.05 to 0.60)
Linear trend P<0.01 P<0.01
Dichotomised (grades 4-6 v
grade 3)
0.39 (0.17 to 0.90) 0.32 (0.11 to 0.88)
*Adjusted for melanin density at upper inner arm, whether ever smoked before age of diagnosis and
amount of sun exposure after onset of disease.
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indicating that ultraviolet radiation may be beneficial
against multiple sclerosis. A strong negative association
was also found in a death certificate based case-control
study among outdoor workers, where the adjusted
odds ratios (95% confidence intervals) for low,
medium, and high regional sunlight for multiple
sclerosis were 0.89 (0.64 to 1.22), 0.52 (0.38 to 0.71),
and 0.24 (0.15 to 0.38) compared with indoor workers
with low ambient sunlight.9 Both ultraviolet radiation
and vitamin D3 have been found to suppress T helper
cell type 1 immune responses through cytokine signal-
ling.6 25 26 Clinical symptoms of experimental allergic
encephalomyelitis—an animal model of multiple
sclerosis—can be prevented or delayed by providing
ultraviolet radiation or 1,25-dihydroxycholecalciferol
(the active form of vitamin D3) at the time of immuni-
sation.6 7 27 A strong inverse correlation (r = − 0.79)
between concentrations of serum 25-hydroxy-
cholecalciferol in a population and mean lesional
activity among people with multiple sclerosis has also
been reported.28 Vitamin D deficiency has been noted
among people with multiple sclerosis,29 and a small
vitamin D and mineral intervention study in patients
with multiple sclerosis showed that less than half the
number of exacerbations occurred after one or two
years compared with the expected number based on
patient case histories.30 Ultraviolet radiation or vitamin
D may also relate to other T helper cell type 1 related
autoimmune diseases such as type 1 diabetes. In a
Finnish birth cohort, regular supplementation with
vitamin D in the first year of life was associated with a
reduced risk of subsequent disease (rate ratio 0.12, 0.03
to 0.51).31
The case sample seemed similar to other
populations with multiple sclerosis of north European
ancestry for disease related features such as type of dis-
ease, age at diagnosis, and sex ratio.11 32 33 Also, the phe-
notypic frequency of the human leucocyte antigen
haplotype DRB1*1501-DQB1*0602 was similar.34 35
Tasmania provides a good setting for this type of study.
Unlike northern Australia, the region has relatively low
levels of ambient ultraviolet radiation in winter, and
exposure to sun in winter is a major determinant of
serum 25-hydroxycholecalciferol concentration in
humans living in this location.16 Participation rates
were high, reducing non-response bias, but it is
possible that some selection bias may have occurred.
The use of measures of past time in the sun could have
led to substantial misclassification of the measurement
of past exposure if participants had resided in locations
with varying levels of ambient ultraviolet radiation, but
a high proportion of participants had lived in
Tasmania for most of their life and their estimated
exposure to ultraviolet radiation would not be
confounded by past residence. A possible weakness of
our study was that prevalent, not incident, cases were
studied. It is unlikely that recall bias fully explains the
observed strong reported associations. The inverse
association between estimated average sun exposure in
early life and multiple sclerosis did not seem to be
caused by the participants’ knowledge of the hypoth-
esis. In fact, the odds ratios for exposure were more
protective for the participants who had indicated that
they did not believe climatic factors such as sun expo-
sure were an important cause of multiple sclerosis.
Also, if the results were caused by recall bias, we would
expect this to affect the results of exposure after age 20
or exposure immediately before the age at onset in a
similar manner, but this was not the case. In addition,
actinic damage, an objective marker of past exposure,
also showed an inverse association with multiple
sclerosis, and this objective marker is free of recall bias.
Disease related changes in behaviour also did not
explain the findings because (a) the protective effect of
greater actinic damage or exposure to sun in
childhood and early adolescence was evident even
among the group with recent onset of multiple sclero-
sis, (b) the strong inverse association between actinic
damage and multiple sclerosis persisted after adjust-
ment for differences in sun exposure that occurred
after onset of multiple sclerosis, and (c) the association
did not differ by duration of disease.
The levels of skin pigmentation in indigenous
populations have evolved to optimise the amount of
ultraviolet radiation absorbed by the skin for the
balance of biological benefits and risks.36 It would be
expected that if a host’s response to ultraviolet
radiation were part of the causal pathway for multiple
sclerosis, risk would vary by levels of skin pigmentation.
Here, fair skin was associated with an increased risk of
multiple sclerosis. Genotypes associated with fair skin
may partially contribute to the higher rate of multiple
sclerosis observed in Scottish and northern European
populations.37
We found that higher sun exposure in winter was
particularly important. In our region, the daily levels of
ambient ultraviolet radiation are more than 10-fold
lower in mid-winter than they are in mid-summer,
compounded by less time spent outdoors.38 This
suggests that, in winter in particular, minimum thresh-
old requirements for sufficient ultraviolet radiation and
vitamin D may not have been met.
The apparent protective effect seemed to be great-
est for sun exposure during childhood and early
adolescence. However, we can only address the timing
issue through self reported data, because actinic
damage measures cumulative damage but cannot pro-
vide data on timing of sun exposure. The finding of no
association between sun exposure in the decade before
onset of multiple sclerosis may indicate that the timing
Age span (years)
Od
ds
 ra
tio
0
0.2
0.3
0.4
0.5
1.0
1.5
2.0
2.5
3.0
0.15
6-10
Total sample
Subsample
6-15 6-20 6-25 6-30 6-35
Association between sun exposure and multiple sclerosis for
different age spans. Odds ratios and 95% confidence intervals for
higher (average 2-3 hours or more a day) sun exposure in summer
during weekends and holidays. Subgroup is participants who did not
believe that sun exposure was an important cause of multiple
sclerosis
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of low exposure may relate more to age related
immunological development than to onset of disease.
In conclusion, higher sun exposure seems to be associ-
ated with a reduced risk of multiple sclerosis, which is
consistent with insufficient ultraviolet radiation influ-
encing the development of multiple sclerosis.
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What is already known on this topic
Multiple sclerosis shows a gradient of increasing
prevalence with latitude
This has been attributed to differences in regional
levels of ultraviolet radiation
Ultraviolet radiation may have a protective role in
T helper cell type 1 mediated autoimmune disease
What this study adds
Higher sun exposure during childhood and early
adolescence and greater actinic damage are
associated with a reduced risk of multiple sclerosis
These associations persisted after adjustment for
fair skin and exposure after onset of disease
Insufficient ultraviolet radiation or vitamin D, or
both, may influence the development of multiple
sclerosis
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